Campbell & Co. Investment Adviser »

Apellis Pharmaceuticals shares owned by Campbell & Co. Investment Adviser

Quarter-by-quarter ownership of Apellis Pharmaceuticals (APLS) shares owned by Campbell & Co. Investment Adviser from 13F filings

Historical chart of Campbell & Co. Investment Adviser investment in Apellis Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including Apellis Pharmaceuticals held by Campbell & Co. Investment Adviser consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Apellis Pharmaceuticals by Campbell & Co. Investment Adviser

Quarter filed Position value Share count Share price at filing
2024-03-31 $2.2M 38k 58.78
2023-06-30 $897k 9.9k 91.10
2023-03-31 $548k 8.3k 65.96
2022-09-30 $1.2M 17k 68.29
2022-06-30 $250k 5.5k 45.23

More positions owned by Campbell & Co. Investment Adviser

United Rentals Common Stock (URI)
Parker-Hannifin Corp Common Stock (PH)
TE Connectivity Common Stock (TEL)
Nov Common Stock (NOV)
Revvity Common Stock (RVTY)
DuPont de Nemours Common Stock (DD)
Credit Acceptance Corp Common Stock (CACC)
State Street Corp Common Stock (STT)
Franklin Resources Common Stock (BEN)
Chubb Common Stock (CB)
McKesson Corp Common Stock (MCK)
Cheniere Energy Common Stock (LNG)
Idacorp Common Stock (IDA)
Jack Henry & Associates Common Stock (JKHY)
Nordson Corp Common Stock (NDSN)

View all positions for Campbell & Co. Investment Adviser

Top funds holding Apellis Pharmaceuticals

Wellington Management Company
EcoR1 Capital
venBio Select Advisor
Vanguard Group
BlackRock
T. Rowe Price Investment Management
Jennison Associates
Octagon Capital Advisors
T. Rowe Price Associates
Jpmorgan Chase & Co
FMR
Assenagon Asset Management
Boxer Capital
Geode Capital Management
Morgan Stanley

View all funds holding Apellis Pharmaceuticals